Evaluation of an open-access heart failure service spanning primary and secondary care

British Journal of Cardiology

Volumn 15, Issue 1, 2008, Pages 35-39

  Patel, Kiran C R ^a,d   Prince, Jennifer ^b   Mirza, Seema ^b   Edmonds, Lucy ^b   Duncan, Rachel ^c   Parry, Joanna ^b   Jerome, Sally ^b   Wozniak, John ^c   Anfilogoff, Nic ^c   Frenneaux, Michael ^b,d   Davies, Michael K ^b,d  

^a SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c South Birmingham Primary Care Trust   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Diagnostics; Echocardiography; Heart failure

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EVALUATION; HEALTH SERVICE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; PRIMARY MEDICAL CARE; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

EID: 39849083032     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Sans S, Kestesloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task force of the European Society of Cardiology on cardiovascular mortality and morbidity statistics in Europe. Eur Heart J 1997;18:1231-48.
2. Davies M, Hobbs F, Davis R et al. Prevalence of left-ventricular systolic dysfunction and HF in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001; 358:439-44.
3. Davis RC, Hobbs FD, Kenkre JE et al. Prevalence of left ventricular systolic dysfunction and HF in high risk patients: community based epidemiological study. BMJ 2002;16:1156.
4. Cowie MR, Mosterd A, Wood DA et al. The epidemiology of HF. Eur Heart J 1997;18:208-25.
5. Mosterd A, Hoes AW, de Bruyne MC et al. Prevalence of HF and left ventricular dysfunction in the general population. The Rotterdam Study. Eur Heart J 1999;20:447-55.
6. Cowie MR, Wood DA, Coats AJW et al. Incidence and aetiology of HF: a population-based study. Eur Heart J 1999;20:421-8.
7. McMurray JJV, Hart W, Rhodes G. An evaluation of the cost of HF to the NHS in the UK. Br J Med Econ 1993;6:99-110.
8. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic HF in the community. Q J Med 1993;86:17-23.
9. Bristow MR, Gilbert EM, Abraham WT et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic HF (MOCHA investigators). Circulation 1996;94:2807-16.
10. Cowie MR, Wood DA, Coats AJ et al. Survival of patients with a new diagnosis of HF: a population based study. Heart 2000; 83:505-10.
11. Hobbs FD, Jones MI, Allan TF, Wilson S, Tobias R. European survey of primary care physician perceptions on HF diagnosis and management (Euro-HF). Eur Heart J 2000;21:1877-87.
12. Hickling JA, Nazareth I, Rogers. The barriers to effective management of HF in general practice. Eur Heart J 2000;21:1877-87. Br J Gen Pract 2001;51:615-18.
13. McClure S, Caruana L, Davie AP, Goldthorp S, McMurray JJ. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. BMJ 1998;317:516-19.
14. Francis CM, Caruana L, Kearney P et al. Open access echocardiography in management of HF in the community. BMJ 1995; 310:634-6.
15. Department of Health. National Service Framework for Coronary Heart Disease, Chapter 6. London: HMSO, 2000.
16. Royal College of Physicians. Chronic Heart Failure. National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. London: Royal College of Physicians, 2003.
17. Aggarwal A, Coca SG, Buller GK, Blaustein DA, Schwenk MH, Pitt B; the EPHESUS Investigators. Eplerenone in Patients with Left Ventricular Dysfunction. N Engl J Med 2003;349:88-9.
18. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive HF: the Framingham study. N Engl J Med 1971; 285:1441-6.
19. Yusuf S, Pfeffer MA, Swedberg K et al; CHARM Investigators and Committees. Effects of candesartan in patients with chronic HF and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81.